SBBC Fundamental Analysis - SIMPLY BETTER BRANDS CORP

Fundamental Rating

Taking everything into account, SBBC scores 3 out of 10 in our fundamental rating. SBBC was compared to 34 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of SBBC have multiple concerns. SBBC is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

SBBC had negative earnings in the past year.

In the past year SBBC had a positive cash flow from operations.

SBBC had negative earnings in each of the past 5 years.

The reported operating cash flow has been mixed in the past 5 years: SBBC reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.47%, SBBC is in the better half of the industry, outperforming 61.76% of the companies in the same industry.

With a Return On Equity value of -22.83%, SBBC perfoms like the industry average, outperforming 44.12% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-1.47%
ROE	-22.83%
ROIC	N/A

ROA(3y)-53.1%

ROA(5y)-47.26%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 29.78%, SBBC perfoms like the industry average, outperforming 52.94% of the companies in the same industry.

In the last couple of years the Gross Margin of SBBC has declined.

The Profit Margin and Operating Margin are not available for SBBC so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	29.78%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-22.17%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SBBC does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, SBBC has more shares outstanding

Compared to 5 years ago, SBBC has more shares outstanding

The debt/assets ratio for SBBC has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.80, we must say that SBBC is in the distress zone and has some risk of bankruptcy.

SBBC has a Altman-Z score (-0.80) which is in line with its industry peers.

The Debt to FCF ratio of SBBC is 6.61, which is on the high side as it means it would take SBBC, 6.61 years of fcf income to pay off all of its debts.

SBBC's Debt to FCF ratio of 6.61 is fine compared to the rest of the industry. SBBC outperforms 76.47% of its industry peers.

SBBC has a Debt/Equity ratio of 2.69. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 2.69, SBBC is not doing good in the industry: 82.35% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	2.69
Debt/FCF	6.61
Altman-Z	-0.8

ROIC/WACCN/A

WACC8.98%

2.3 Liquidity

A Current Ratio of 0.90 indicates that SBBC may have some problems paying its short term obligations.

With a Current ratio value of 0.90, SBBC is not doing good in the industry: 79.41% of the companies in the same industry are doing better.

SBBC has a Quick Ratio of 0.90. This is a bad value and indicates that SBBC is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.74, SBBC is doing worse than 70.59% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.9
Quick Ratio	0.74

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

SBBC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.61%, which is quite impressive.

Looking at the last year, SBBC shows a very negative growth in Revenue. The Revenue has decreased by -42.52% in the last year.

SBBC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.58% yearly.

EPS 1Y (TTM)98.61%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%57.93%

Revenue 1Y (TTM)-42.52%

Revenue growth 3Y42.58%

Revenue growth 5YN/A

Sales Q2Q%3.75%

3.2 Future

Based on estimates for the next years, SBBC will show a very strong growth in Earnings Per Share. The EPS will grow by 29.10% on average per year.

SBBC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.80% yearly.

EPS Next Y0%

EPS Next 2Y29.1%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year41.19%

Revenue Next 2Y35.8%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

SBBC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year SBBC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBBC indicates a somewhat cheap valuation: SBBC is cheaper than 64.71% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	46.81
EV/EBITDA	N/A

4.3 Compensation for Growth

SBBC's earnings are expected to grow with 29.10% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y29.1%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for SBBC!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SIMPLY BETTER BRANDS CORP

TSX-V:SBBC (8/29/2025, 7:00:00 PM)

0.68

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)06-02 2025-06-02

Earnings (Next)08-25 2025-08-25

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap73.17M

Analysts84

Price Target2.3 (238.24%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)28.57%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-200%

EPS NY rev (3m)-200%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-2.13%

Revenue NY rev (3m)-2.13%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.16
P/FCF	46.81
P/OCF	46
P/B	32.22
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.01

EYN/A

EPS(NY)-0.04

Fwd EYN/A

FCF(TTM)0.01

FCFY2.14%

OCF(TTM)0.01

OCFY2.17%

SpS0.59

BVpS0.02

TBVpS-0.03

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.47%
ROE	-22.83%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	29.78%
FCFM	2.48%

ROA(3y)-53.1%

ROA(5y)-47.26%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-22.17%

GM growth 5YN/A

F-Score5

Asset Turnover1.79

Health

		Industry Rank	Sector Rank
Debt/Equity	2.69
Debt/FCF	6.61
Debt/EBITDA	N/A
Cap/Depr	1.3%
Cap/Sales	0.04%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.9
Quick Ratio	0.74
Altman-Z	-0.8

F-Score5

WACC8.98%

ROIC/WACCN/A

Cap/Depr(3y)2.76%

Cap/Depr(5y)N/A

Cap/Sales(3y)0.18%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)98.61%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%57.93%

EPS Next Y0%

EPS Next 2Y29.1%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-42.52%

Revenue growth 3Y42.58%

Revenue growth 5YN/A

Sales Q2Q%3.75%

Revenue Next Year41.19%

Revenue Next 2Y35.8%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y73.34%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year274.76%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y133.86%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y134.46%

OCF growth 3YN/A

OCF growth 5YN/A

SIMPLY BETTER BRANDS CORP (SBBC.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens